Yissum: Clearmind Medicine, Yissum expand collaboration with patent application for Generation 3.0 psychedelic compounds to treat mental disorders
Clearmind Medicine Inc, a biotech company focused on discovery and development of novel psychedelic─derived therapeutics to solve major under─treated health problems, has announced the submission of a patent
Read full article »
Yissum serves as a bridge between academic research and a community of entrepreneurs, investors, and industry organizations.
Read more